The Trump administration just announced a program of actions to tackle the so-called “autism epidemic”, a term that is disputed by many within the autistic community. As well as seeking Food and Drug Administration (FDA) approval for a new drug treatment, safety label changes are being pursued for acetaminophen (paracetamol) due to a “potential association” between its use in pregnancy and neurodevelopmental conditions. The rest of this article is behind a paywall. Please sign in or subscribe to access the full content.
They told us way back in April that they would “know” the causes of autism by September . As predicted, the new announcements from the US Department of Health and Human Services (HHS) cannot go as far as that, but they do bring forth a suite of “bold actions” that many